New York State Common Retirement Fund Crispr Therapeutics Ag Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

A detailed history of New York State Common Retirement Fund transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, New York State Common Retirement Fund holds 1,228 shares of CRSP stock, worth $49,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,228

Previous 1,228 -0.0%

Holding current value

$49,144

Previous $66,000 12.12%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$38.62 - $72.18 $47,425 - $88,637	1,228 New	1,228 $77,000
Q2 2022 Aug 04, 2022	SELL	$43.23 - $73.83 $256,526 - $438,107	-5,934 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$53.19 - $79.24 $106,380 - $158,480	2,000 Added 50.84%	5,934 $372,000
Q4 2021 Feb 02, 2022	BUY	$70.09 - $111.29 $10,513 - $16,693	150 Added 3.96%	3,934 $298,000
Q2 2021 Aug 02, 2021	SELL	$100.84 - $161.89 $105,882 - $169,984	-1,050 Reduced 21.72%	3,784 $613,000
Q1 2021 May 11, 2021	SELL	$110.72 - $210.04 $333,267 - $632,220	-3,010 Reduced 38.37%	4,834 $589,000
Q4 2020 Feb 08, 2021	BUY	$79.67 - $173.23 $415,080 - $902,528	5,210 Added 197.8%	7,844 $1.2 Million
Q1 2020 May 06, 2020	SELL	$33.68 - $62.53 $101,410 - $188,277	-3,011 Reduced 53.34%	2,634 $112,000
Q4 2019 Feb 05, 2020	BUY	$36.68 - $73.13 $112,277 - $223,850	3,061 Added 118.46%	5,645 $344,000
Q3 2019 Nov 07, 2019	BUY	$40.99 - $52.56 $18,445 - $23,652	450 Added 21.09%	2,584 $106,000
Q2 2019 Aug 09, 2019	SELL	$35.45 - $48.2 $7,090 - $9,640	-200 Reduced 8.57%	2,134 $101,000
Q1 2019 May 08, 2019	SELL	$28.02 - $40.87 $4,203 - $6,130	-150 Reduced 6.04%	2,334 $83,000
Q4 2018 Feb 08, 2019	SELL	$22.73 - $42.34 $104,989 - $195,568	-4,619 Reduced 65.03%	2,484 $71,000
Q3 2018 Nov 07, 2018	SELL	$44.35 - $65.71 $110,342 - $163,486	-2,488 Reduced 25.94%	7,103 $315,000
Q2 2018 Aug 10, 2018	SELL	$42.62 - $73.59 $4,262 - $7,359	-100 Reduced 1.03%	9,591 $564,000
Q1 2018 May 10, 2018	BUY	$23.52 - $58.17 $26,036 - $64,394	1,107 Added 12.9%	9,691 $443,000
Q4 2017 Feb 13, 2018	SELL	$16.95 - $23.48 $181,229 - $251,048	-10,692 Reduced 55.47%	8,584 $202,000
Q3 2017 Nov 06, 2017	BUY	$16.75 - $20.66 $322,873 - $398,242	19,276	19,276 $344,000

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.12B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Crispr Therapeutics Ag Transaction History